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Service utilization and suicide among people with schizophrenia spectrum disorders 
Abstract  
Objective: To compare individuals with and without schizophrenia spectrum disorders (SSD) 
(schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified) who die 
by suicide.   
Method:  This is a retrospective case control study which compared all individuals who died by 
suicide in Ontario, Canada with (cases) and without (controls) SSD between January 1, 2008 and 
December 31, 2012. Cases (individuals with SSD) were compared to controls on demographics, 
clinical characteristics, and health service utilization proximal to suicide. A secondary analysis 
compared the characteristics of those with SSD and those with severe mental illness (defined as 
those without SSD who have had a psychiatric hospitalization within the five-years before 
suicide (excluding the 30 days prior to death)). 
Results: Among 5,650 suicides, 663 (11.7%) were by individuals with SSD. Compared to other 
suicides, SSD suicides were significantly more likely to be between the ages of 25-34. SSD 
suicide victims were significantly more likely to reside in the lowest income neighbourhoods and 
to reside in urban areas. SSD victims were also significantly more likely to have comorbid mood 
and personality disorders and all types of health service utilization, including outpatient mental 
health service contact in the 30 days prior to death, even when compared only with those who 
had a history of mental health hospitalization. 
Conclusions: Individuals with schizophrenia spectrum disorder account for over 1 in 10 suicide 
deaths, tend to be younger, poorer, urban, more clinically complex, and have higher rates of 
mental health service contact prior to death. The demographic and service utilization differences 
persist even when the SSD group is compared with a population with severe mental illness that is 
not SSD. Suicide prevention strategies for people with schizophrenia spectrum disorder should 
emphasize the importance of clinical suicide risk assessment during clinical encounters, 
particularly early in the course of illness.  
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Introduction 
People with schizophrenia spectrum disorders (SSD) have significantly higher rates of death by 
suicide compared with the general population.(Bjorkenstam et al., 2014; Brugnoli et al., 2012; 
Fazel et al., 2014; Nordentoft et al., 2011, 2004) Studies report a lifetime risk of 4-5% with 
evidence that risk of suicide is highest early in the course of illness.(Bakst et al., 2010; Dutta et 
al., 2012; Fleischhacker et al., 2014; Palmer et al., 2005) Suicide is the leading cause of 
premature death in SSD, and identifying individuals with SSD who are at high risk for death by 
suicide is an important clinical, research and public health priority.(Fleischhacker et al., 2014) 
Epidemiological studies have identified population-based risk factors that are routinely 
incorporated into clinical assessments to identify, and intervene with, individuals at high risk of 
suicide. However, individuals with SSD may differ from the general population with respect to 
suicide risk factors and may require different types of suicide interventions. There are few (or 
no?) studies that systematically compare those who die by suicide in SSD vs. other psychiatric 
diagnoses. Furthermore, the generalizability of existing studies is limited by small sample sizes, 
the use of clinical samples, and diagnoses made retrospectively through psychological 
autopsy.(Banwari et al., 2013; Cavanagh et al., 2003; Lopez-Morinigo et al., 2014) Suicide is a 
rare outcome and a retrospective, population-based study and validated algorithm for diagnosis 
ascertainment allows for a rigorous analysis of the percentage of suicide victims with SSD and 
the differences in demographics, clinical features and mental health service utilization in those 
with and without a diagnosis of SSD.  
The objective of this study was to examine the characteristics of those who die by suicide with 
and without SSD. Our hypothesis was that individuals with SSD would have a much larger 
suicide prevalence relative to best estimate of a population-based one-year prevalence rate of 0.6 
3 
(95% CI 0.38-0.91) and will have uniquely different suicide risk factors compared to individuals 
who die by suicide without SSD.(Goldner et al., 2002)  
Methods 
Data Sources 
2QWDULRLV&DQDGD¶VPRVt populous province, with approximately 13 million people.(Open Minds 
+HDOWK\0LQGV2QWDULR¶V&RPSUHKHQVLYH0HQWDO+HDOWKDQG$GGLFWLRQV6WUDWHJ\, 2011)  The 
Ontario Ministry of Health and Long-Term Care provides coverage for all medically necessary 
services to residents and captures administrative data reflecting health care utilization. The 
Institute for Clinical Evaluative Sciences (ICES) holds these health administrative data sources 
which are linked via an encrypted unique identifier. The Office of the Registrar ± Deaths (ORG-
D) database captures all deaths in Ontario and includes cause of death, including suicide. The 
Registered Persons Database (RPDB) captures demographic information including date of birth, 
sex, residential neighbourhood, and date of death. The Ontario Health Insurance Plan (OHIP) 
database captures information related to physician billings, including visit date and diagnosis. 
The National Ambulatory Care Reporting System (NACRS) identifies emergency department 
service utilization and diagnosis. The Ontario Mental Health Reporting System (OMHRS) 
captures information from hospitalizations occurring in psychiatric beds starting in 2005 and the 
Canadian Institutes of Health Information Discharge Abstract Database (CIHI-DAD) captures 
information from hospitalizations in non-psychiatric beds. 
Study Participants 
The study sample consists of all Ontario residents who died by suicide between January 1, 2008 
and December 31, 2012. Suicides were captured by several databases (ORG-D, NACRS, 
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OMHRS and DAD) and were cross referenced to create a cohort of unique suicides.  We 
identified the majority (n = 5,697, 96%) of suicides within ORG-D using ICD-10 codes. A small 
number of suicides (N=219, 4%) were also identified in NACRS (death by suicide during an ED 
visit), OMHRS (suicide during psychiatric inpatient hospitalization), or DAD (death by suicide 
during inpatient hospitalization). Subjects were excluded if they had an invalid Ontario health 
card number within 5 years of death (n = 265, < 5%). 
Within this sample, all individuals who were diagnosed with a schizophrenia spectrum disorder 
(SSD) (schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified) in 
Ontario between July 1, 1993 and December 1, 2012 were identified by a validated 
algorithm.(Kurdyak et al., 2015) The July 1, 1993 start date was chosen to maximise the number 
of subjects who were diagnosed with SSD captured while maintaining consistent data quality. 
The end date was chosen to ensure that service utilization 30 days prior to death by suicide was 
not double counted as both a diagnostic and service utilization factor. The diagnostic algorithm 
included all individuals who received these diagnoses at hospitalization discharge or during three 
visits to a physician over a 36-month period (sensitivity 93%; specificity 59%, PPV 66%, NPV 
91%). This algorithm has the advantage of including SSD cases that are not routinely 
hospitalized, and therefore generates a SSD sample that is more representative of the entire 
population instead of a more acutely ill sample. 
 Schizophrenia and schizoaffective disorder are typically included in population-based studies on 
schizophrenia spectrum disorders. Psychotic disorder not otherwise specified (NOS) is also 
included because its presence improves test characteristics for health administrative data 
algorithms. In addition, the majority of individuals with a psychotic disorder NOS diagnosis are 
eventually diagnosed with schizophrenia or schizoaffective disorder.(Kurdyak et al., 2015; Pope 
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et al., 2013) This algorithm was FRQVLVWHQWZLWKSUHYLRXVOLWHUDWXUHZKHUH³VFKL]RSKUHQLD´
³VFKL]RSKUHQLDVpectrum GLVRUGHUV´DQG³QRQ-DIIHFWLYHSV\FKRVHV´DUHXVHGLQWHUFKDQJHDEO\LQ
suicide research.(Fazel et al., 2014; Gallego et al., 2015; Høye et al., 2011)  
A secondary analysis compared the schizophrenia spectrum disorders group with a subgroup of 
controls who had a previous history of mental health hospitalization in the 5-year period before 
death excluding the 30 days prior to death. Hospitalizations were included if they appear in 
CIHI-DAD with a mental illness discharge diagnosis (F00-F09; F20-F99) or if they were 
included in OMHRS. These groups were compared to ensure that the demographic, clinical and 
service utilization differences found in the first comparison were specific to SSD and not simply 
related to having a serious mental illness.  
Covariates 
Sociodemographic characteristics included age by group (<24, 25-34, 44-54, 54-64, 65+), 
gender, neighborhood income quintile at the Census tract level and rurality of residence at time 
of death. Neighbourhood income quintile was derived from Canadian Census data captured in 
2006. Rurality at time of death was determined by the Rurality Index of Ontario (RIO) score. 
The RIO uses postal codes to assign a score on a 100-point scale.(Kralj, 2000) A score of 40 or 
greater was considered a rural residence. 
Comorbidities included a measure of general comorbidity, a diagnosis of an alcohol use disorder 
or of a drug use disorder and diagnoses of a mood disorder or personality disorder (excluding the 
30 days before death). General comorbidity, including both medical and psychiatric/psychosocial 
comorbidity, was measured using Johns Hopkins Aggregated Diagnosis Groups (ADGs).(Austin 
et al., 2011)  Johns Hopkins ADGs are  predictors of mortality in the general population and in a 
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schizophrenia population.(Austin et al., 2012, 2011) Presence of an alcohol use disorder was 
determined by including all subjects who, within five years of death, were diagnosed with an 
alcohol use disorder by any physician in any setting (OHIP-based ICD-9 code 291 or 303), were 
diagnosed with an alcohol use disorder or related condition in an emergency department or 
medical inpatient setting (ICD-10 diagnostic code F100-F109, G312, G621, I426, K292, K700-
K703, K709, R780, or T510), or a diagnosis of an alcohol use disorder in a psychiatric inpatient 
setting (ICD-9 diagnostic code 291 or 303). Presence of a drug use disorder was determined by 
including all subjects who, within five years of death, were diagnosed with an drug use disorder 
by any physician in any setting (OHIP-based ICD-9 code 292 or 304), were diagnosed with an 
drug use disorder or related condition in an emergency department or medical inpatient setting 
(any of ICD-10 diagnostic codes F11.0-F16.9; F18.0-F18.9; T40.0-40.9, T41.3; T42.3-42.4 in 
NACRS or DAD), or were diagnosed with a drug use disorder in a psychiatric inpatient setting 
(ICD-9 diagnostic code 292 or 304). Presence of a mood disorder was determined by including 
all subjects who, within five years of death, were diagnosed with either a mood disorder or 
depressive disorder in any clinical setting (OHIP-based ICD-9 code: 296 or 311).  Presence of a 
personality disorder was determined by including subjects who, within five years of death, were 
diagnosed with these illnesses in any clinical setting (OHIP-based ICD-9 code: 301) 
Previous suicide-related behaviour requiring emergency care or hospitalization was ascertained 
through NACRS using ICD-10 codes for deliberate self-harm with either firm or undermined 
intent (X60-X84, Y10-Y19, Y28), in keeping with previous literature validating this approach 
using ICES data.(Bethell and Rhodes, 2009) Previous suicide-related behaviour was measured 
within the five years prior to death by suicide as well as in the 30 days prior to death by suicide. 
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Health service utilization covariates were measured 5 years prior to death by suicide (excluding 
the 30 days prior to death), as a measure of general health system engagement and burden of 
psychiatric illness, and in the 30 days prior to death by suicide, as a potential opportunity for 
suicide intervention. Health service utilization measures included outpatient psychiatrist, primary 
care, and non-psychiatrist specialist visits, ED visits and hospitalizations. Primary care physician 
visits were categorized as mental health vs. non-mental health-related visits based on a validated 
algorithm.(Steele et al., 2004) ED visits were included if they were related to a NACRS 
discharge diagnosis of an ICD-10 mental health or addictions code (F00-F09; F20-F99). 
Hospitalizations were included if they appear in CIHI-DAD with a mental illness discharge 
diagnosis (F00-F09; F20-F99) or if they were included in OMHRS.  
Statistical Analysis 
Descriptive statistics (t-tests for continuous variables, Chi-square/Mantel-Haenszel for 
dichotomous and ordinal variables) were used to compare completed suicide cases with 
schizophrenia spectrum disorder vs. those without. We also used logistic regression to determine 
the variables that were independently associated with a schizophrenia spectrum disorder 
diagnosis in those who die by suicide. The primary variable was the presence or absence of SSD 
among people who died by suicide. The covariates of interest included sociodemographic 
characteristics (sex, age by category, rural residence, neighbourhood income quintile), 
comorbidities within five years and 30 days of death (general medical comorbidity measure, 
presence of alcohol use disorder, presence of drug use disorder), history of suicide-related 
behaviour requiring medical attention (within five years and 30 days of death), and health service 
utilization data including outpatient psychiatric care, ED visits for mental health reasons, and 
mental health hospitalization (within five years and 30 days of death).   
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Results 
Cohort Development 
5,697 suicides were identified from the ORG-D database and a further 219 were identified from 
other data sources in Ontario between January 1, 2008 and December 31, 2012 (Table 1). After 
excluding 1 case with a missing death date and 265 cases because they were not eligible for 
coverage under the OHIP in the 5 years prior to suicide death, there were 5,650 suicide deaths 
included in this study, among whom 663 (11.7%) were associated with a diagnosis of 
schizophrenia, schizoaffective disorder or psychosis not otherwise specified.   
Demographic characteristics 
SSD suicides accounted for 10.3% of all male suicides, and 15.7% of all female suicides (Table 
2).  The SSD suicide group had a greater proportion of female suicides than the non-SSD group, 
and were significantly younger, accounting for 21.7% of all suicides in the 25 - 34 age group and 
only 7.7% of all suicides over the age of 65 (Table 2).  SSD suicide victims were significantly 
less likely to live in rural areas and were more likely to reside in the lowest income 
neighbourhoods (Table 2). 
Comorbidities 
The Aggregated Diagnosis Group (ADG) score over the last five years was significantly higher 
in the schizophrenia group; they were also significantly more likely to have been diagnosed with 
an alcohol use disorder or a drug use disorder (Table 2).  They were significantly more likely to 
have a diagnosis of other illnesses associated with suicide, such as mood disorder or personality 
disorder. Individuals with schizophrenia spectrum disorders were significantly more likely to 
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have had an episode of suicidal behaviour requiring emergency care or hospitalization over the 
last five years.   
Service Utilization Characteristics (proximal to death) 
Individuals with schizophrenia spectrum disorders were significantly more likely to have mental 
health system contact in the 30 days before death by suicide than those without.  They were more 
likely to see a primary care provider (PCP) for mental health reasons or a psychiatrist as an 
outpatient, visit an ED for mental health reasons and to be hospitalized for mental health reasons.  
A combined variable for outpatient access (PCP or psychiatrist) within the last 30 days prior to 
death by suicide showed that 45.4% of individuals with schizophrenia spectrum disorders 
received care, compared with 20.9% of individuals without (Table 2).  A combined variable 
measuring any mental health care (outpatient, ED or hospitalization) raised the percentage of 
individuals with schizophrenia spectrum disorders who had received care to 53.4% compared 
with only 25.9% of those without these diagnoses (Table 2).  
Comparison with subgroup with history of psychiatric hospitalization 
A secondary comparison of suicide victims with a diagnosis of schizophrenia spectrum disorder 
and suicide victims with a history of psychiatric hospitalization in the five years prior to death 
(excluding the 30 days before death) was conducted to ensure that the demographic, clinical and 
proximal service utilization differences seen in the SSD group compared to the control group is 
specific to SSD rather than severity of mental illness in general.  
1,111suicide victims who did not have a diagnosis of SSD, or 19.7% of the total sample, were 
hospitalized for mental health reasons between 5 years and 30 days before death by suicide 
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within the same time period (Table 3). 60.8% of suicide deaths were male, significantly lower 
than the rate seen in the overall sample (73.7%), but not statistically significant from the SSD 
group. The SSD group were significantly more likely to be between the ages of 25-34 at time of 
death) and significantly less likely to be over the age of 65. The SSD group had a significantly 
higher proportion within the lowest income quintile and were less likely to live in rural areas 
(Table 3).  
With respect to clinical diagnoses, as expected, both the SSD and serious mental illness groups 
had higher rates of diagnosed alcohol use disorder, drug use disorder, mood disorders and 
personality disorder than the overall sample (Table 3).  However, the serious mental illness 
group had significantly higher rates of alcohol use disorder and drug use disorder compared with 
the SSD group. Rates of mood disorder diagnoses were not significantly different (Table 3). 
Interestingly, higher rates of personality disorder diagnoses were observed in the SSD group than 
the serious mental illness group, and suicide attempts requiring ED visit or hospitalization in the 
five years before death were significantly more likely in the SMI group (Table 3).   
In the 30 days prior to death, no significant differences between the SSD and SMI groups were 
found in presence of any visit to primary care provider for mental health reasons, any visit to ED 
for mental health or mental health hospitalizations.  However, suicide victims with SSD were 
significantly more likely to have seen a psychiatrist within the last 30 days prior to death, and 
more likely to have had any mental health care (Table 3). 
Regression Analysis 
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A logistic regression analysis was conducted to determine the sociodemographic characteristics, 
comorbidities, and patterns of service utilization that are independently related to a diagnosis of 
schizophrenia in those who died by suicide (Table 4).  
A schizophrenia diagnosis was significantly more likely in the 24-34 age group compared to the 
reference range of 45-64 (adjusted odds ratio (AOR) = 1.86, (95% CI 1.44 - 2.42)) (Table 4). 
 Residing in an area within the top four income quintiles were negatively associated with an SSD 
diagnosis; for example, the adjusted odds ratio for income quintile 5 (the highest) was 0.50 (95% 
CI 0.37-0.67) (Table 4). Rural residence was negatively associated with an SSD diagnosis (AOR 
= 0.68 (95% CI 0.50-0.912 (Table 4).   
The pattern of service utilization in the five years before death provided the strongest predictors 
of an SSD diagnosis in those who die by suicide. Mental health hospitalization within the five 
years before death strongly predicted an SSD diagnosis (AOR = 7.03 (95% CI 5.59 ± 8.84)), as 
did the presence of any outpatient visit to a family physician or psychiatrist for mental health 
reasons (AOR = 3.84 (95% CI 2.55 ± 5.77) (Table 4). Additional diagnoses of a mood disorder 
(AOR = 1.25 (95% CI 1.03 ± 1.55)) or personality disorder (AOR = 2.12 (95% CI 1.61 ± 2.80)) 
were associated with an SSD diagnosis (Table 4). The presence of suicidal behaviour within 5 
years of suicide completion was negatively associated with an SSD diagnosis in our model (AOR 
= 0.75, (95% CI 0.59-0.96)) (Table 4). Finally, any outpatient mental health care within 30 days 
of death was independently predictive of an SSD diagnosis (AOR = 1.63, (95% CI 1.34 ± 1.98)) 
(Table 4).  
A second regression model was completed to see what factors predict an SSD diagnosis 
compared to the group of people with a history of psychiatric hospitalization in the absence of a 
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SSD diagnosis (Table 5).  All variables were identical except for hospitalization within the last 
five years, which was removed from the regression as this was the defining feature of the 
psychiatric hospitalization group.  In this model, the significant predictors of schizophrenia were 
identical to the model above, with three exceptions: 1)  
1) alcohol use disorder was a negative predictor of a SSD diagnosis (AOR = 0.73 (95% CI 0.57 ± 
0.93)), 2) mood disorder diagnosis within five years of death was not predictive of a SSD 
diagnosis (AOR = 1.00 (95% CI 0.80 ± 1.25), and 3) outpatient mental health care in the five 
years prior to death was not a significant predicator of an SSD diagnosis (AOR = 1.32 (95% CI 
0.81 ± 2.14)) 
Discussion 
Over 1 in every 10 suicide deaths in Ontario over a five-year period are associated with a 
diagnosis of SSD. This estimate is likely the most accurate to date due to the large number of 
suicides over a large geographic area and duration, as well as the use of a validated algorithm 
designed to identify cases of SSD diagnosed both in hospital and in the community. SSD 
diagnoses are strongly overrepresented in those who die by suicide, as the prevalence of 
schizophrenia spectrum disorder in the general population is less than 1%.(Goldner et al., 2002) 
Our study revealed several important demographic differences between suicide victims with and 
without SSD. Strikingly, almost one out of every four people with SSD who died by suicide was 
between the ages of 25-34 and over half the individuals with SSD who died by suicide were 
younger than 45 years of age, unlike the non-SSD population, where almost 60% were over age 
45. Many studies have identified young age as a predisposing risk factor for suicide in people 
with schizophrenia.(Hor and Taylor, 2010) Small studies comparing those with schizophrenia 
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who die by suicide with other suicide victims have also suggested that this group is significantly 
younger.(Ishii et al., 2014; Sinyor et al., 2015) Suicide victims with schizophrenia were 
significantly more likely to live in major urban areas.  Rural residence has been associated with 
higher rates of suicide worldwide.(Hirsch, 2006; Zaheer et al., 2011) Prevalence of schizophrenia 
and related disorders, however, has been shown to be higher in urban areas.(Krabbendam and 
van Os, 2005; Lewis et al., 1992)  
Our study also highlighted large differences in health service utilization in the 30 days prior to 
death. Whether prior mental health service utilization differs among those with schizophrenia 
compared to those without schizophrenia has not been studied previously. In the 30 days before 
death by suicide, 56% of those with a diagnosis of schizophrenia or related disorders accessed 
some form of mental health care, compared with 27% of the non-schizophrenia group. Receiving 
outpatient mental health care was independently predictive of a having a diagnosis of 
schizophrenia. This rate of mental health services contact is much higher than the 1 in 5 
previously cited.(Luoma et al., 2002; Pearson et al., 2009) The frequent access to psychiatric 
care provides opportunities to screen for suicidal ideation and behaviour, and to implement risk 
management plans in a group of patients we have identified as high risk.  
In order to ensure that the differences we observed were related to diagnosis specific factors 
rather than simply a function of having a severe mental illness, a secondary comparison and 
regression analysis was conducted comparing those who die by suicide with SSD and those who 
die by suicide and have a history of hospitalization within the five years prior to death (excluding 
the 30 days before death). The predictors of a schizophrenia diagnosis were identical to those 
comparing the SSD group to the full sample, with only three exceptions ± a history of outpatient 
mental health treatment or diagnosis of a mood disorder within the five years prior to death did 
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not differentiate the two groups, and, unlike the comparison between SSD suicides and all non-
SSD suicides, SSD suicide victims were significantly less likely to have a history of alcohol use 
disorder compared to suicide victims with severe mental illness.  
In general, our findings highlight the importance of a comprehensive suicide risk assessment 
among individuals with schizophrenia.(Pompili et al., 2016, 2008) This is especially important 
given the high rate of mental health service use contact in the 30 days prior to suicide.(Giupponi 
et al., 2014)  
Limitations 
Our study has several limitations. The gold standard for diagnosis would be a standardized 
assessment and not a service utilization algorithm; however, we used a validated algorithm to 
detect cases with psychotic disorder diagnoses that shows high sensitivity and moderate 
specificity.  We are limited to the data available via administrative databases; as such we do not 
have information on risk factors for suicide including family history, medications prescribed, 
expressed suicidal ideation or psychosocial stressors. Finally, we can only ascertain suicide when 
it is coded as such in vital statistics data. It is likely that the number of suicides captured in this 
study is an underestimate of the true number of suicides, but it is unclear whether individuals 
with or without schizophrenia spectrum disorder would be more affected by this likely source of 
missing data. 
These limitations are balanced by a large, population-based ascertainment of suicides among 
which we identified individuals with a diagnosis of schizophrenia or related disorders that were 
ascertained through both ambulatory and hospitalization settings. Consequently, this is a very 
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large, representative sample that likely provides, to our knowledge, the most accurate estimates 
of schizophrenia-specific suicide risk factors. 
Conclusions 
Our study findings suggest that those with schizophrenia spectrum disorder diagnoses are 
overrepresented in a sample of those who die by suicide, comprising 11.7% of all suicide deaths, 
compared to a population prevalence of approximately 1%. SSD suicide victims are younger, 
more likely to reside in areas in the bottom income quintile and in urban areas, and more likely 
to seek mental health care in the month prior to death by suicide. The results indicate that 
clinicians need to be vigilant about suicide risk in young individuals with schizophrenia 
spectrum disorder, particularly in major urban areas. Our results also suggest that there may be 
opportunities to intervene because many individuals with schizophrenia spectrum disorders who 
die by suicide have had contact with the health care system, and most frequently with mental 
health care providers.  
 
 
Table 1. Subject Inclusion and Exclusion 
Description Exclusions Patients 
 
Suicides from Ontario Registered Persons Database (ORPD)   5697 
 Suicides from other sources   219 
 Total suicides   5916 
 Excluded because missing death date 1 5915 
 
Excluded because not Ontario Health Insurance Plan (OHIP) 
eligible 5 years before suicide 
265 5650 
 Schizophrenia Spectrum Disorders (SSD)          663 
 Non-SSD   4987 
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Table 2.  Demographic, clinical and service utilization characteristics of 663 with Schizophrenia spectrum disorders 
(SSD) diagnosis vs. 4987 without SSD diagnosis 
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Variable 
All subjects  
(n = 5650) 
Schizophrenia 
(n = 663) 
No 
Schizophrenia 
(n = 4987) 
P-Value* 
Demographics           
Sex, (n, %)           
M 4163 (73.7%) 429 (64.7%) 3734 (74.9%) 
< 0.0001 
F 1487 (26.3%) 234 (35.3%) 1253 (25.1%) 
          
Age (mean, SD) 47.3, SD 17.6 43.7, SD 14.4 47.8, SD 17.9 < 0.0001 
Age group (n, %)         
< or = 24 702 (12.4%) 57 (8.6%) 645 (13.0%) 0.0011 
25-34 695 (12.3%) 144 (21.7%) 551 (11.1%) < 0.0001 
35-44 1010 (17.9%) 142 (21.4%) 868 (17.5%) 0.011 
45-64 2357 (41.7%) 269 (40.6%) 2088 (42.0%) 0.53 
65+ 886 (15.7%) 51 (7.7%) 835 (16.8%) < 0.0001 
            
Income Quintile, (n,%)           
1  ? low 1424 (25.2%) 250 (37.7%) 1174 (23.5%) < 0.0001 
2  ? medium low 1148 (20.3%) 122 (18.4%) 1026 (20.6%) 0.020 
3  ? medium 1086 (19.2%) 108 (16.3%) 978 (19.6%) 0.041 
4  ? medium high 991 (17.5%) 87 (13.1%) 904 (18.1%) 0.0013 
5  ? high 942 (16.7%) 91 (13.7%) 851 (17.1%) 0.031 
Missing 59 (1.0%) <6      
            
Rural residence  
          
Yes 940 (16.6%) 62 (9.4%) 878 (17.6%) < 0.0001 
No 4699 (83.2%) 600 (90.5%) 4099 (82.2%) 
 Missing 11 (0.2%) 
 
<6   
            
Clinical Characteristics (excluding 30 days 
before death)           
Aggregated Diagnosis Group (ADG) score 
over last five years (mean, SD) 8.1 SD 4.3 9.0 SD 4.3 8.0 SD 4.3 < 0.0001 
Alcohol use disorder diagnosis within the last 
five years (n, %) 1032 (18.3%) 188 (28.4%) 844 (16.9%) < 0.0001  
Drug use disorder diagnosis within the last 
five years (n, %) 1235 (21.9%) 276 (41.6%) 959 (19.2%) < 0.0001 
Mood disorder diagnosis within the last five 
years (n, %) 1804 (31.9%) 411 (62.0%) 1393 (27.9%) < 0.0001 
Personality disorder diagnosis within the last 
five years (n, %) 331 (5.9%) 124 (18.7%) 207 (4.2%) < 0.0001 
Any visit to primary care provider (PCP) for 
mental health reasons within the last five 
years (n, %) 
3507 (62.1%) 572 (86.3%) 2935 (58.9%) < 0.0001 
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*P Value ʹ reflects comparison of Schizophrenia vs. No Schizophrenia sample. 
  
Any visit to an outpatient psychiatrist within 
the last five years (n, %) 2092 (37.0%) 568 (85.7%) 1524 (30.6%) < 0.0001 
Any visit to emergency department (ED) for 
mental health reasons within the last five 
years (n, %) 1704 (30.2%) 506 (76.3%) 1198 (24.0%) < 0.0001 
Any mental health hospitalization within the 
last five years (n, %) 
1615 (28.6%) 504 (76.0%) 1111 (22.3%) < 0.0001 
Any suicidal behaviour requiring emergency 
department (ED) care within the last five 
years (n, %) 
784 (13.9%) 187 (28.2%) 597 (12.0%) < 0.0001 
Proximal mental health service utilization          
Any visit to primary care provider (PCP) for 
mental health reasons within the last one 
month (n, %) 
829 (14.7%) 132 (19.9%) 697 (14.0%) 0.004 
Any visit to psychiatrist within the last one 
month (n, %) 663 (11.7%) 210 (31.7%) 453 (9.1%) < 0.0001 
Any visit to emergency department (ED) for 
mental health reasons within the last one 
month (n, %) 394 (7.0%) 82 (12.4%) 312 (6.3%) < 0.0001 
Any mental health hospitalization within the 
last one month (n, %) 
424 (7.5%) 87 (13.1%) 312 (6.3%) < 0.0001 
Combined outpatient access (PCP or 
Psychiatrist) within last one month (n, %) 
1342 (23.8%) 301 (45.4%) 1041 (20.9%) < 0.0001 
Any mental health care (Outpatient, ED or 
hospitalization) within the last one month (n, 
%) 
1649 (29.2%) 355 (53.5%) 1294 (25.9%) <0.0001 
Any suicidal behaviour requiring emergency 
department (ED) care within the last one 
month (n, %) 
419 (7.4%) 47 (7.1%) 372 (7.5%) 0.73 
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Table 3.  Demographic, clinical and service utilization characteristics of 663 with Schizophrenia spectrum disorders 
(SSD) diagnosis vs. 1111 with serious mental illness*  
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Variable 
Schizophrenia 
Spectrum 
Disorders (n = 
663) 
Non-Schizophrenia 
Mental Illness* (n = 
1111) 
P-Value 
Demographics         
Sex, (n, %)         
M 429 (64.7%) 676 (60.8%) 
0.11 
F 234 (35.3%) 435 (39.2%) 
        
Age (mean, SD) 43.7 SD 14.4 47.5, SD 16.7 < 0.001 
Age group (n, %)       
< or = 24 57 (8.6%) 118 (10.6%) 0.17 
25-34 144 (21.7%) 133 (12.0%) < 0.001 
35-44 142 (21.4%) 218 (19.6%) 0.36 
45-64 269 (40.6%) 482 (43.4%) 0.25 
65+ 51 (7.7%) 160 (14.4%) < 0.001 
          
Income Quintile, (n,%)         
1  ? low 250 (37.7%) 261 (23.5%) < 0.001 
2  ? medium low 122 (18.4%) 271 (24.4%) 0.003 
3  ? medium 108 (16.3%) 208 (18.7%) 0.20 
4  ? medium high 87 (13.1%) 175 (15.8%) 0.13 
5  ? high 91 (13.7%) 189 (17.0%) 0.066 
Missing <6      
          
Rural residence  
        
Yes 62 (9.4%) 155 (14.0%) 0.016 
No 600 (90.5%) 954 (85.9%) 
 Missing 
 
<6   
          
Clinical Characteristics (excluding 30 days 
before death)         
Aggregated Diagnosis Group (ADG) score over 
last five years (mean, SD) 9.0 SD 4.3 10.0 SD 4.0 < 0.001 
    
Alcohol use disorder diagnosis within the last 
five years (n, %) 188 (28.4%) 408 (36.7%) < 0.001  
Drug use disorder diagnosis within the last five 
years (n, %) 276 (41.6%) 517 (46.5%) 0.044 
Mood disorder diagnosis within the last five 
years (n, %) 411 (62.0%) 667 (60.0%) 0.42 
22 
Personality disorder diagnosis within the last five 
years (n, %) 124 (18.7%) 115 (10.4%) < 0.001 
Any visit to primary care provider (PCP) for 
mental health reasons within the last five years 
(n, %) 
572 (86.3%) 969 (87.2%) 0.57 
Any visit to an outpatient psychiatrist within the 
last five years (n, %) 568 (85.7%) 796 (71.6%) < 0.001 
Any visit to emergency department (ED) for 
mental health reasons within the last five years 
(n, %) 506 (76.3%) 741 (66.7%) < 0.001 
Any mental health hospitalization within the last 
five years (n, %) 
504 (76.0%) 1111 (100.0%) < 0.001 
Any suicidal behaviour requiring emergency 
department (ED) care within the last five years 
(n, %) 
287 (28.7%) 453 (40.8%) < 0.001 
Proximal mental health service utilization        
Any visit to primary care provider (PCP) for 
mental health reasons within the last one month 
(n, %) 
132 (19.9%) 213 (19.2%) 0.70 
Any visit to psychiatrist within the last one 
month (n, %) 210 (31.7%) 234 (21.1%) < 0.001 
Any visit to emergency department (ED) for 
mental health reasons within the last one month 
(n, %) 82 (12.4%) 115 (10.4%) 0.55 
Any mental health hospitalization within the last 
one month (n, %) 
87 (13.1%) 147 (13.2%) 0.95 
Combined outpatient access (PCP or Psychiatrist) 
within last one month (n, %) 
301 (45.4%) 393 (35.4%) < 0.001 
Any mental health care (Outpatient, ED or 
hospitalization) within the last one month (n, %) 
355 (53.5%) 485 (43.7%) <0.001 
23 
*Non-Schizophrenia Mental Illness includes individuals who had a psychiatric hospitalization in 
the 5 years prior to suicide. 
  
 
 
Table 4: Logistic regression results associated with schizophrenia among the total suicide 
sample. 
Factor 
Odds 
Ratio 
95% Confidence 
Limits 
p-value 
Demographics       
sex M vs F 1.04 0.85  ? 1.28 0.71 
Age, <24 vs 45-64 0.84 0.60 - 1.18 0.31 
Age, 25-34 vs 45-64 1.86 1.44  ? 2.42 < 0.0001 
Age, 35-44 vs 45-64 1.21 0.95 - 1.55 0.12 
Age, >=65 vs 45-64 0.74 0.53  ? 1.05 0.09 
Income quintile, 2nd vs 1
st
 (lowest) 0.52 0.40 - 0.68 < 0.0001 
Income quintile, 3rd vs 1st 0.53 0.40 - 0.69 < 0.0001 
Income quintile, 4th vs 1st 0.47           0.35  ? 0.63 < 0.0001 
Income quintile, 5th vs 1st 0.50 0.37 - 0.67 < 0.0001 
Rural vs. urban 0.68 0.50  ? 0.92 0.012 
Clinical Characteristics       
Aggregated Diagnosis Group (ADG) score, within 
five years of death 
0.96 0.94  ? 0.99 0.003 
Alcohol use disorder diagnosis, within five years 
of death 
0.83 0.66  ? 1.05 0.12 
Drug use disorder diagnosis, within five years of 
death 
1.10 0.88  ? 1.38 0.41 
Mood disorder diagnosis, within five years of 
death 
1.26 1.03  ? 1.55 0.028 
Personality disorder diagnosis, within five years of 
death 
2.12 1.61  ? 2.80 < 0.0001 
Any outpatient mental health visit, within five 
years of death (family physician or psychiatrist) 
3.84 2.55  ? 5.77 < 0.0001 
Any suicidal behaviour requiring emergency 
department (ED) care within the last one month 
(n, %) 
47 (7.1%) 111 (10.0%) < 0.001  
24 
Any mental health hospitalization, within five 
years of death  
7.03 5.59  ? 8.84 < 0.0001 
Any suicidal behaviour requiring emergency 
department or hospital care, within five years of 
death 
0.75 0.59  ? 0.96 0.021 
Proximal Mental Health Service Utilization       
Any outpatient mental health visit, within one 
month of death (family physician or psychiatrist) 
1.63 1.34  ? 1.98 < 0.0001 
Any mental health hospitalization, within one 
month of death 
1.20 0.88  ? 1.64 0.25 
Any suicidal behaviour requiring emergency 
department or hospital care, within one month of 
death 
0.73 0.50  ? 1.07 0.11 
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Table 5: Logistic regression results associated with schizophrenia among individuals with 
schizophrenia or non-schizophrenia mental illness*.  
 
Factor 
Odds 
Ratio 
95% Confidence 
Limits 
p-value 
Demographics       
sex M vs F 1.06 0.85  ? 1.32 0.63 
Age, <24 vs 45-64 0.87 0.60  ? 1.27 0.48 
Age, 25-34 vs 45-64 1.86 1.38  ? 2.50 < 0.0001 
Age, 35-44 vs 45-64 1.17 0.89 - 1.53 0.28 
Age, >=65 vs 45-64 0.71 0.49  ? 1.03 0.067 
Income quintile, 2nd vs 1
st
 (lowest) 0.47 0.35 - 0.63 < 0.0001 
Income quintile, 3rd vs 1st 0.54 0.40 - 0.73 < 0.0001 
Income quintile, 4th vs 1st 0.49           0.36  ? 0.68 < 0.0001 
Income quintile, 5th vs 1st 0.48 0.35 - 0.66 < 0.0001 
Rural vs. urban 0.66 0.47  ? 0.92 0.014 
Clinical Characteristics       
Aggregated Diagnosis Group (ADG) score, within 
five years of death 
0.95 0.93  ? 0.98 0.0005 
Alcohol use disorder diagnosis, within five years 
of death 
0.73 0.57  ? 0.92 0.0085 
Drug use disorder diagnosis, within five years of 
death 
0.99 0.78  ? 1.26 0.94 
Mood disorder diagnosis, within five years of 
death 
1.00 0.80  ? 1.25 0.99 
Personality disorder diagnosis, within five years 
of death 
1.92 1.42  ? 2.59 < 0.0001 
Any outpatient mental health visit, within five 
years of death (family physician or psychiatrist) 
1.32 0.81 - 2.14 0.27 
Any suicidal behaviour requiring emergency 
department or hospital care, within five years of 
death 
0.59 0.46  ? 0.75 < 0.0001 
Proximal Mental Health Service Utilization       
Any outpatient mental health visit, within one 
month of death (family physician or psychiatrist) 
1.47 1.18 ? 1.83 0.0005 
Any mental health hospitalization, within one 
month of death 
1.08 0.77  ? 1.50 0.66 
26 
Any suicidal behaviour requiring emergency 
department or hospital care, within one month of 
death 
0.77 0.51  ? 1.15 0.20 
*Non-Schizophrenia Mental Illness includes individuals who had a psychiatric hospitalization in 
the 5 years prior to suicide. 
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